Image
  • About Us
  • Team
  • Portfolio
  • Philanthropy
  • Trending
  • Contact
  • Login

Argos Therapeutics´ Immunotherapy Platform Based on Recombinant Human Soluble CD83 Demonstrates Significant Promise For Solid Organ Transplantation

admin May 4, 2011 Portfolio News

Learn More-External Link

Back

Topics

News Archives

Image
Privacy Policy Terms of Use©2022 Lumira Ventures
  • About Us
  • Team
  • Portfolio
  • Philanthropy
  • Trending
  • Contact
  • Login